Antisynthetase syndrome without myositis secondary to AA amyloidosis: A non-described association;Síndrome antisintetasa sin miositis con amiloidosis secundaria AA: una asociación no descrita

Nefrologia

Volumn 31, Issue 1, 2011, Pages 117-119

  Toledo, K ^a   Perez M J ^a   Espinosa, M ^a   Ortega, R ^a   Aljama, P ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COLORING AGENT; CONGO RED; DIAGNOSTIC AGENT; HISTIDINE TRANSFER RNA LIGASE; JO 1 ANTIBODY; JO-1 ANTIBODY; SERUM AMYLOID A;

AGED; AMYLOIDOSIS; ANTISYNTHETASE SYNDROME; AUTOIMMUNE DISEASE; BIOPSY; BLOOD; CASE REPORT; CHRONIC KIDNEY FAILURE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOLOGY; LETTER; MALE; MYOSITIS; PATHOLOGY;

AGED; AMYLOIDOSIS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY; COLORING AGENTS; CONGO RED; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HISTIDINE-TRNA LIGASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MYOSITIS; SERUM AMYLOID A PROTEIN;

EID: 79951820483     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Sep.10469     Document Type: Letter

References (7)

1. Clinical manifestacions and diagnosis of adult dermatomyositis and polymyositis of adult dermatomyositis. Uptodate 2008.
2. Marañas A, López-Gallardo Y, García A, Miguélez M, Abella ML, Bethencourt M. Síndrome antisintetasa sin afectación miosítica: a propósito de un caso. An Med Intern 2005;4:182-4.
3. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatr 2000;68:472-8.
4. Yazici Y, Kagen LJ. Clinical presentation of the idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:823-32.
5. Tournadre A, Amarger S, Pascal J, D'Incan M, Ristori J, Soubrier M. Polymyositis and pemphigus vulgaris in a patient: Successful treatment with rituximab. Joint Bone Spine 2008;75:728-9.
6. Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted theraphy with therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
7. Wedling D. Biologics in the treatment of primary inflammatory myositis. Joint Bone Spine 2007;74:316-8.